Dr. Reddy’s Laboratories has bagged the USFDA approval for Sevalamer Carbonate for oral suspension. Shares of the company, however, were trading in the red zone. 

Sun Pharma’s arm, the Massachusetts based DUSA Pharmaceuticals, has been awarded a preliminary injunctive relief from the US court in the case of patent contravention.

Crude oil hits a low of US$54.28 per barrel, tumbling 5 per cent to its lowest price since mid-September of 2017.

Vakrangee gained approximately 4 per cent intraday as the company launched domestic money transfer services at its Nextgen outlets.

Omkar Speciality Chemicals can now produce Halquinol product on receiving the grant of the process patent. The stocks hit its upper circuit limit on Thursday morning. 

KEC International has won orders across multiple business arms accumulating to Rs. 1,491 crore.

Shares of Strides Pharma traded in positive in early trade on Wednesday as the company is set to receive US$42 million from Agila transaction.

Skipper, manufacturer of power transmission and distribution structures, has bagged an order worth Rs. 150 crore for 2,500 towers from multiple telecom operators

Pharma major Glenmark has received the final approval from United States Food and Drug Association (USFDA) for Fluocinolone Acetonide Oil, 0.01 per cent. The stock was trading 0.81 per cent higher.

IT giant Infosys gained on the bourses as the company declared the formation of a JV with Hitachi, Panasonic Corporation and Pasona Inc. Shares of the company gained almost 3 per cent intraday.

Mumbai based Fintech start-up, 5paisa Capital Limited strengthened its position in the discount broking segment as its active client base increased by 486 per cent YoY. The company now has an active client base of 83,328 against 14,217 a year ago.

Strides Pharma’s step-down wholly-owned subsidiary, Strides Pharma Globe Pte. Limited, Singapore, received USFDA approval for Lidocaine Ointment. The stocks of Strides gained 2 per cent in the morning trading session.

Subsidiary of Hinduja Group, Ashok Leyland has signed an MoU with ELBIT Systems, Israel. The shares of the company gained more than 2 per cent intraday on Wednesday.

Lupin has received tentative approval from USFDA to market Apixaban Tablets, 2.5 mg and 5 mg. The tablet is indicated to treat several ailments including reducing the risk of stroke and systemic embolism.

Pharma major Alembic Pharmaceuticals received approval from the USFDA for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%. The stocks gained around 2 per cent intraday post the news.

The power transmission & distribution business segment of Larsen and Toubro (L&T) has won orders worth Rs 2,547 crore. The shares of the company gained over 1 per cent intra-day. 

The USFDA completed inspection of pharma major, Lupin’s units at Mandideep location and issued multiple observations over three units located there. Shares of Lupin have thus plunged intraday on Wednesday.

The construction arm of Larsen&Toubro has won orders across two of its business segment, viz. Water and Effluent Treatment Business and L&T GeoStructure.

Shares of Kridhan gained about 6 per cent at the opening bell on accounts of its associate company, Vijay Nirman adding Rs. 105 crore to its order book. 

BSE has recorded first ever delivery in Gold and Silver Contracts. BSE had commenced trading commodities segment with effect from Oct 1, 2018. 

The auto sales numbers for November have kicked in with four-wheeler sales showing a drop on a YoY basis. Maruti and Tata witnessed a marginal drop. On the other hand, two-wheeler sales inched higher with TVS hitting 27 per cent increase and Hero Motocorp up by 16 per cent. The drop in the overall volumes can be attributed to a tepid festive season along with the liquidity crisis in the NBFC sector, leading to lesser auto loans. 

L&T has won orders worth Rs. 1,127 crore across its two business segments namely, Metallurgical & Material Handling Business and Buildings & Factories Business

Zydus Cadila has received the final approval for Teriflunomide tablets from the United States of Food and Drug Association (USFDA). Shares of the company could most likely be in limelight on Monday’s trading session.

Dr. Reddy’s Laboratories has launched Chlorthalidone Tablets USP, 25 mg and 50 mg. The company's share, however, fell intraday. 

The wholly-owned subsidiary of Reliance Industries, Reliance Industrial Investments and Holdings has invested in New Emerging World of Journalism (NEWJ).

Zydus Cadila has received the final USDFA approval for Baclofen Tablets, 10mg and 20mg. The shares of the company, however fell intraday.

Alembic Pharmaceuticals has collected yet another USFDA approval, now for Temazepam Capsules. The shares of the company gained almost 3 per cent intraday. 

Alembic Pharma’s joint venture, Aleor Dermaceuticals has received USFDA approval for Lidocaine Ointment USP. Shares of the company were up by almost 2 per cent intraday.

Glenmark has received tentative approval for Colobetasol Propionate Foam from the USFDA. The shares of the company were trading on the positive side in the early trading hours of Monday.

Pennar group’s flagship company, Pennar Industries has received multiple orders totaling up to Rs 190 crore across its business segments. 

Glenmark has been granted the final USFDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL. The shares of the company opened 0.7 per cent higher than its previous close. 

Pharma major Lupin on receiving approval from the USFDA has launched Tetrabenazine Tablets. The shares of the company were trading in green.

Reliance Mutual Fund (RMF) announced Further Fund Offer 3 (FFO3) of the Central Public Sector Enterprises - Exchange Traded Fund (CPSE ETF). 

The company has received USFDA approval for vardenafil hydrochloride orally disintegrating Tablets, 10 mg. The shares of the company were trading 0.97 per cent higher.

Glenmark has received the final USFDA approval for Azelaic Gel used for acne and rosacea.

The shares of Surya Roshni closed 2 per cent higher in Monday’s trading session as the company announced winning orders worth Rs 59 crore from Government of Odisha Housing and Urban Department. 

The shares of Global Capri rose 7 per cent intra-day post the announcement of the robust quarterly results.

The pharma major Glenmark has won final USFDA approval for Teriflunomide Tablets, 7 mg and 14 mg. The shares of the company rose 1.5 per cent in the early trade following the announcement.

Capacit'e Infraprojects has won an order worth Rs. 207.80 crore. The shares of the company were trading up by almost 1 per cent during Wednesday's trading session.

Motherson Sumi Systems has posted a 16 per cent drop in its consolidated net profit for Q2FY19 at Rs. 495.48 crore as against Rs. 593.45 crore in Q2FY18.

InvaGen Pharmaceuticals, a subsidiary of pharma major Cipla, is set to acquire Avenue Therapeutics, a NASDAQ listed pharmaceutical company. The shares of Cipla, however, were trading marginally down at 0.54 per cent in the morning trading session.

The following stocks could be in focus in Tuesday’s trading session in light of their results: Apollo Tyres, Ashok Leyland, CG Power, Deepak Fertilizer and Glenmark Pharmaceuticals.

Tata Communications has installed a next-gen software-defined hybrid network for Carlsberg. Shares of Tata Communications were up approximately 2 per cent around noon.

The following stocks could be in focus in Tuesday’s trading session in light of their results: Graphite, Dr. Lal PathLabs, Manappuram Finance,Voltas and Cupid.

Pharma major Lupin announced receiving the approval for its Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vials from USFDA. 

Uflex posted robust results as the net sales surged 22.49 per cent in Q2FY19 and stood at Rs. 1,072.82 crore as against Rs. 875.83 crore in the corresponding quarter of the previous year.

On Friday, Sensex zoomed more than 500 points and Nifty gained 170 points and were at 10,548.85 and 34,963.75, respectively at 11:00 am. 

The following stocks could be in focus in Tuesday’s trading session in light of their results: Axis Bank, Bata India, Bharat Forge, Gabriel India and GSFC

Greaves Cotton limited, one of India's leading engineering companies, reported revenue growth for H1 FY19 at 11% to Rs. 953 crore as against Rs. 859 crore in H1 FY18. EBITDA for half year ended September 30th, 2018 grew by 9% to Rs. 134 crore as against Rs. 123 crore in the corresponding H11ast year. 

On the last trading day of October, the Indian equities market's breadth closed in favour of advances with an advance-decline ratio at 2:1. The BSE Sensex closed at 34,442.05, up by 550.92 points or 1.63 per cent, while the broader benchmark index Nifty50 closed at 10,386 level, up by 1.85 per cent. 

The company on Wednesday reported its Q2FY19 earnings.

The following stocks would be in focus during Tuesday’s trading session in light of their Q2FY19 results announcement: Bank of Baroda, Aksharchem, JK Tyre, Abb India and Emami. 

Cipla has received a final approval from the USFDA for Abbreviated New Drug Application (ANDA) for Metoprolol ER Tablets 50mg, 100mg, 200mg. Shares of the company gained in early trade on Monday.

The following stocks could be in focus in Monday’s trading session in light of their results: Punj lloyd, Divi's Laboratory, Salzer Electronics, Sintex Industries and Vinati Organics.

On the opening day of the new series, the key benchmark index Sensex slipped by more than 1 per cent and managed to close at 33,349 levels.

The company posted its Q2 numbers on Friday and the company’s revenue has jumped 20 per cent YoY and stood at Rs. 3,937.99 crore in Q1FY19 versus Rs. 3,258.66 crore.

Glenmark Pharmaceuticals Inc., USA has received the final approval from the USFDA for FS topical oil. Shares of the company, however, slipped on Friday morning.

The following stock could be in focus in Friday’s trading session in light of their results announcment: UPL, ICICI Bannk, ITC, Dr Reddy and Nestle.

The company’s consolidated Q2 new loss was narrowed to Rs. 33 crore from a net loss of Rs. 455.6 crore accrued in Q2FY18. The revenue of the company has gone up by 43 per cent and came in at Rs 1,084.3 crore versus Rs 754.7 crore.

Markets inched lower on Thursday taking cues from global markets. Sensex was down by 1.01 per cent closing at 33,690.09, with only six index stocks managing to close in the green.  

L&T Finance Holdings’ Q2 consolidated net profit rose by approximately 65 per cent and came in at Rs. 560.41 crore as against Rs. 337.53 crore in the same quarter of the previous fiscal year. Gross NPA was down to Rs. 6,119 crore, while net NPA was at Rs. 2,296 crore.

Tata Chemicals (TCL) has signed an agreement with a government research institute in Tamil Nadu to explore collaborative technology scaling up of manufacturing of cathode materials for Lithium-ion cells.

The following stocks are likely to be in focus in tomorrow’s trading session in light of their Q2FY19 results : BHEL, BIOCON, Dish TV, Force Motors and Yes Bank.

Bharti Airtel will be raising close to US$1.25 billion by selling stakes in its African business. 

Cyient and Suntech have signed a partnership agreement to pursue business opportunities, globally. Shares of Cyient were trading on a positive note during Wednesday's trading session.

Ahluwalia Contracts (India) Limited has announced that the company has been awarded Rs. 538.76 crore for a project in Lucknow. Shares of the company dipped below 3 per cent.

Aleor Dermaceuticals Ltd, a joint venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies has cleared its first USFDA inspection.

Strides Pharma Science Limited has announced that Strides Pharma Global Pte. Limited, Singapore, a step-down wholly-owned subsidiary of Strides has received approval for Gabapentin capsules USP, 100 mg, 300 mg, and 400 mg from the United States Food & Drug Administration (USFDA). 

Lupin announced that its Pithampur unit-3 in Indore went through the USFDA inspection that was conducted from October 8 to October 18, 2018. The shares closed down by almost 2  per cent. 

The Benchmark Indian indices BSE Sensex and Nifty50 both opened in red following the losses posted by the US and Asian markets.

IIFL Wealth Management Ltd  announced it would acquire the entire share capital and the company of Chennai-based Wealth Advisors India Private Limited (Wealth Advisors).  IIFL Wealth will conclude the transaction for a consideration of INR 235 Crore. The transaction is subject to regulatory approvals. 

Symbo India Insurance Broking (Symbo), a digital insurance brokerage firm, in partnership with Reliance General Insurance and event ticketing company Goeventz has launched Marathon Insurance – a unique cover for marathon runners.

Glenmark Pharmaceuticals has been given a nod from the USFDA for Hydrocortisone Valerate Cream. The shares of the company went up by over 2 per cent.

RajCOMP Info Services, a Govt of Rajasthan Undertaking has awarded a Letter Of Intent (LoI) to ITI Limited to execute RajNet project.

Global Pharmaceutical company Zydus Cadila has received the tentative approval from the USFDA to market Linagliptin and Metformin HydrochlorideTablets. The tablets will be manufactured in Ahmedabad, India.

M&M and Castrol India have inked a new strategic partnership agreement. Following this development, the stocks of M&M surged in Friday’s trading session.

The benchmark Indian indices reacted sharply to the sell-off in the US markets opening gap-down on Thursday morning. BSE Sensex opened at 34,063 level down by 2 per cent, while Nifty50 fell by over 2.7 per cent and opened at 10,192 level. 

Kritika Wires Limited, a Kolkata-based company, got listed on Emerging platform of National Stock Exchange at a premium of 6.5 per cent. 

Shares of Lupin were slightly up after the company launched generic clobetasol propionate ointment in the US.

Mahindra Agri Solutions (MASL), a subsidiary of Mahindra & Mahindra (M&M) has incorporated a subsidiary ‘Mahindra Summit Agriscience’ from October 9, 2018.

Anil Ambani’s Reliance Health Insurance, a wholly-owned subsidiary of Reliance Capital, announced that it has received R3 approval from IRDAI for its new health insurance business.

The central government on Thursday brought down petrol and diesel prices by Rs 2.50. For the same, the government has asked oil marketing companies (OMCs) to absorb Re. 1 per litre to bring down fuel prices. 

IFC, a member of the World Bank Group, has extended a 7-year long-term loan of Rs. 1,000 crore to Aditya Birla Finance Limited. (ABFL), the NBFC arm of Aditya Birla Capital Limited (ABC). ABFL is a diversified non-banking finance company (NBFC)

The construction arm of L&T has secured orders across its two business segments. The total order is valued at Rs. 1,477 crore. The share of L&T remained flat in the morning session

The stocks that are likely to witness significant movement on the bourses on September 27 are Torrent Power, Sanwaria Consumer, HCL, Gayatri Projects and SBI. 

Liberty Shoes Limited has announced that the company is expanding its portfolio to become a complete lifestyle brand under Liberty Lifestyle. The company has launched a fragrance line for both men and women. The shares of Liberty Shoes have climbed up by 2 per cent intraday on Wednesday.

Kolkata-based company, Anmol Industries Limited, has received approval from SEBI for its IPO. Anmol is one of the leading FMCG companies in India. The company had filed its DRHP in June 2018.  

The subsidiary of Mercator, Mercator Petroleum Limited has begun the oil production and dispatch from its first well, Jyoti-1 in Cambay basin. Reacting to the news, shares of the Mercator surged almost 2 per cent intraday on Monday.

The rating agency CRISIL has upgraded the ratings of Muthoot HomeFin India Ltd (MHIL) term loans, working capital demand loan and proposed long term bank facility to ’CRISIL AA/Stable’ from ’CRISIL AA-/Stable’.  

Gravita India Limited, a leading recycling company, has said that the company has expanded the capacity of its existing plant located at Chittoor, Andhra Pradesh, by installing new washing line and PPCP granules extrusion lines having annual capacity of 4,800 MTPA.

Dilip Buildcon has emerged as the L-1 bidder for the Indore metro project. Post the news, the company's stock rose by over 2 per cent intra-day on Friday. 

BSE receives another feather in its hat by getting SEBI’s approval to launch Commodity Derivatives Segment from October 1, 2018.

Dinesh Engineers Limited, a passive communication infrastructure company will be launching its initial public offering.  

The stocks that are likely to witness significant movement on the bourses on September 19 are Indian Hume Pipe Company, ICICI Prudential, Sun Pharma, Som Distilleries and Breweries and Strides Pharma.

The stocks that are likely to witness significant movement on the bourses on September 18 are Indraprastha Gas, Alembic Pharmaceuticals, Avenue Supermarts, IL&FS Transportation Networks Limited and SMS Lifesciences. 

Global pharmaceutical company, Zydus Cadila has received the tentative approval from USFDA for Sitagliptin. 

BSE along PTC India Limited and ICICI Bank Limited  filed a petition with the power market regulator, CERC (Central Electricity Regulatory Commission) on September 7, 2018 for grant of license for setting up a new power exchange.

Power Mech has received a Letter of Intent for several work orders totalling to Rs. 247 crore. The share price of the company has however remained modest.